Up 473% in a year, should I buy PLS shares today?

PLS – formerly Pilbara Minerals – leads the ASX 200's top one-year gains board. But can the ASX lithium stock keep racing higher?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

PLS Group Ltd (ASX: PLS) shares have been on fire over the past year.

In afternoon trade on Tuesday, shares in the S&P/ASX 200 Index (ASX: XJO) lithium stock– formerly known as Pilbara Minerals – were trading for $6.54 each.

While shares lost ground on Tuesday, that sees the PLS share price up a blistering 473.3% over the past 12 months, smashing the 3.4% one-year gains posted by the benchmark index.

To put this performance in some perspective, if you'd bought $10,000 worth of the ASX lithium stock on 2 June 2025, you'd be sitting on $57,325 today.

Atop its own operational successes above and below the ground, the Aussie miner has enjoyed strong tailwinds from the ongoing global resurgence in lithium demand.

With only limited new supplies coming into play over the past year, this has sent spodumene (a lithium bearing ore) prices up around 196% in 12 months.

Which brings us back to our headline question.

With the stock having surged so much in the past year…

A white EV car and an electric vehicle pump with green highlighted swirls representing ASX lithium shares

Image source: Getty Images

Should I buy PLS shares now?

Catapult Wealth's Dylan Evans recently analysed the growth outlook for the Aussie lithium miner (courtesy of The Bull).

"PLS is an Australian lithium producer, with its primary operation in Western Australia," he noted.

Commenting on the company's recent performance, Evans said:

PLS has a solid balance sheet. Revenue of $624 million in the first half of 2026 was up 47% on the prior corresponding period. Driving growth is a combination of increasing demand for lithium and near-term supply constraints.

As for that solid balance sheet, as at 31 March PLS reported a cash balance of $1.45 billion. That was up 52% from 31 December.

Connecting the dots, Evans issued a hold recommendation on PLS shares following their huge run higher.

He concluded:

Demand is fuelled by growing battery and electric vehicle adoption, which has been boosted by the conflict in Iran and crude oil disruptions. The strong balance sheet and free cash flow should enable PLS to fund its expansion plans.

What's the latest from the ASX 200 lithium stock?

PLS released its third quarter update on 24 April.

Highlights for the three months included an impressive 52% quarter on quarter increase in revenue to $567 million.

That revenue boost was driven by a 61% increase in the average realised spodumene price PLS received over the quarter.

The ASX 200 lithium miner also increased its quarterly spodumene production by 12% to 232,400 tonnes, and it sold 195,700 tonnes over the three months.

PLS shares closed up 1.6% on the day of the results release.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Boys making faces and flexing.
Small Cap Shares

3 ASX small-cap shares to buy: Morgans

ASX small caps are underperforming in 2026, but Morgans sees opportunity with these 3 companies.

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Broker Notes

Three ASX shares to buy right now according to Morgans

One of these shares is tipped to more than double.

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Broker Notes

Down 28% in a year, should I buy the dip on Resmed shares right now?

A leading analyst provides his outlook for the beaten-down ResMed share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A businessman points to an arrow going up on a graph, indicating a share price rise for an ASX company.
Broker Notes

Up 1,277% in a year, why 4DMedical shares are tipped for more outsized gains

A leading analyst forecasts more outperformance from 4DMedical’s rocketing shares. But why?

Read more »

An oil worker in front of a pumpjack using a tablet.
Broker Notes

Why Woodside shares just got a big buy call

A leading analyst forecasts more outperformance from Woodside’s surging shares.

Read more »

A woman smiles at the outlook she sees through binoculars.
Broker Notes

Buy, hold, sell: 4DMedical, Cochlear, Westpac shares

An expert discusses his views on Westpac shares and 2 other popular ASX 200 stocks.

Read more »

Woman in business suit holds both hands out with a question mark above each hand.
Broker Notes

Buy, hold, sell: Ampol, Lendlease, BHP shares

Let's check out some new ratings on 3 ASX 200 shares today.

Read more »